Literature DB >> 10378881

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

S A Kolb1, B Sporer, F Lahrtz, U Koedel, H W Pfister, A Fontana.   

Abstract

Central nervous system (CNS) involvement is a prominent feature of human immunodeficiency virus (HIV-1) infection. Monocytes and CD4+ T cells traverse the blood brain barrier (BBB), and serve as vehicles for the virus and perpetrators for brain pathology by their production of neurotoxins. In the present study cerebrospinal fluid (CSF) samples from HIV-1-infected patients were analyzed for the presence of chemotactic factors. All 36 CSF samples from the patients were positive for the CXC chemokine interferon-gamma inducible protein (IP-10), which was not detected in CSF samples of 14 controls. The IP-10 concentrations were higher in HIV-1-infected patients with HIV-1 associated neurologic disorders than in those without neurological deficits. In contrast to IP-10, other chemotactic factors including the CC chemokines MCP-1, MIP-1alpha, MIP-1beta and RANTES and the cytokines IL-15 and IL-16 were either not detected or increased in only less than 30% of the patients. Unlike the CSF samples of controls, all CSF samples from HIV-1-infected patients induced chemotaxis of T cells activated with IL-2. The significance of IP-10 as a T cell chemotactic cytokine in HIV-1-infected CSF is shown by (1) the correlation of the IP-10 levels with the extent of T cell chemotaxis, (2) the neutralization of T cell chemotaxis by anti-IP-10 antibodies and (3) the correlation of the chemotactic response of CSF samples on activated T cells and the CSF white cell count in the patients. Our data provide evidence that IP-10 contributes to the accumulation of activated T cells in the CSF compartment in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378881     DOI: 10.1016/s0165-5728(98)00223-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  64 in total

1.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

2.  Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis.

Authors:  Yongjun Sui; Raghava Potula; Navneet Dhillon; David Pinson; Shanping Li; Avindra Nath; Carol Anderson; Jadwega Turchan; Dennis Kolson; Opendra Narayan; Shilpa Buch
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 3.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

4.  Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virus.

Authors:  Rick B Meeker; D C Bragg; Winona Poulton; Lola Hudson
Journal:  Cell Tissue Res       Date:  2012-01-27       Impact factor: 5.249

5.  A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.

Authors:  Lynn Pulliam; Hans Rempel; Bing Sun; Linda Abadjian; Cyrus Calosing; Dieter J Meyerhoff
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

6.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

7.  Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Authors:  V C Asensio; J Maier; R Milner; K Boztug; C Kincaid; M Moulard; C Phillipson; K Lindsley; T Krucker; H S Fox; I L Campbell
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 8.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

9.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

10.  Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.

Authors:  Navneet Dhillon; Xuhui Zhu; Fuwang Peng; Honghong Yao; Rachel Williams; Jianming Qiu; Shannon Callen; Amy O'Brien Ladner; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.